Abstract
Friend murine erythroleukemia (MEL) cells are transformed erythroid precursors that are held in an immature and proliferating state but can be induced to differentiate in vivo by treatment with a variety of chemical agents such as N, N-hexamethylene bisacetamide (HMBA). To investigate the role of Myb proteins in maintaining MEL cells in an immature and proliferating state we have produced stable transfectants in the C19 MEL cell line that contain a dominant interfering Myb allele (MEnT) under the control of an inducible mouse metallothionein I promoter. When expression of MEnT protein was induced with ZnCl2, the stable transfectants differentiated with kinetics that were similar to wild type C19 MEL cells treated with HMBA, including induction of α-globin mRNA expression, assembly of hemoglobin and growth arrest. Expression of endogenous c-myb and c-myc was also decreased in response to MEnT. Expression of mad-1 mRNA was rapidly increased in response to expression of MEnT resulting in a shift from predominantly c-Myc/Max complexes to predominantly Mad/Max containing complexes. These results strongly suggest that C19 MEL cells are held in an immature and proliferating state by a pathway that is dependent on Myb activity.
Similar content being viewed by others
References
Allen RD, Bender TP, Siu G . 1999 Genes Dev. 13: 1073–1078
Aziz N, Miglarese MR, Hendrickson RC, Shabanowitz J, Sturgill TW, Hunt DF, Bender TP . 1995 Proc. Natl. Acad. Sci. USA 92: 6429–6433
Badiani P, Corbella P, Kioussis D, Marvel J, Weston K . 1994 Genes Dev. 8: 770–782
Ben-David Y, Letwin K, Tannock L, Bernstein A, Pawson T . 1991 EMBO J. 10: 317–325
Bender TP, Kuehl WM . 1986 Proc. Natl. Acad. Sci. USA 83: 3204–3208
Bies J, Hoffman B, Amanullah A, Giese T, Wolff L . 1996 Oncogene 12: 355–363
Casadevall N, Lacombe C, Muller O, Gisselbrecht S, Mayeux P . 1991 J. Biol. Chem. 266: 16015–16020
Chern YJ, O'Hara C, Sytkowski AJ . 1991 Blood 78: 991–996
Clarke MF, Kukowska-Latallo JF, Westin E, Smith M, Prochownik EV . 1988 Mol. Cell. Biol. 8: 884–892
Cogswell JP, Cogswell PC, Kuehl WM, Cuddihy AE, Bender TP, Engelke U, Marcu KB, Ting JP . 1993 Mol. Cell. Biol. 13: 2858–2869
Craig RW, Bloch A . 1984 Cancer Res. 44: 442–446
Cultraro CM, Bino T, Segal S . 1997 Mol. Cell. Biol. 17: 2353–2359
Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S . 1986 Nature 322: 748–750
Dugaiczyk A, Haron JA, Stone EM, Dennison OE, Rothblum KN, Schwartz RJ . 1983 Biochemistry 22: 1605–1613
Duprey SP, Boettiger D . 1985 Proc. Natl. Acad. Sci. USA 82: 6937–6941
Ess KC, Witte DP, Bascomb CP, Aronow BJ . 1999 Oncogene 18: 1103–1111
Frampton J, Ramqvist T, Graf T . 1996 Genes Dev. 10: 2720–2731
Friend C, Scher W, Holland JG, Sato T . 1971 Proc. Natl. Acad. Sci. USA 68: 378–382
Gewirtz AM, Anfossi G, Venturelli D, Valpreda S, Sims R, Calabretta B . 1989 Science 245: 180–183
Golay J, Broccoli V, Lamorte G, Bifulco C, Parravicini C, Pizzey A, Thomas NSB, Delia D, Ferrauti P, Vitolo D, Introna M . 1998 J. Immunol. 160: 2786–2793
Golay J, Capucci A, Arsura M, Castellano M, Rizzo V, Introna M . 1991 Blood 77: 149–158
Golay J, Luppi M, Songia S, Palvarini C, Lombardi L, Aiello A, Delia D, Lam K, Crawford DH, Biondi A, Barbui T, Rambaldi A, Introna M . 1996 Blood 87: 1900–1911
Gonda TJ, Metcalf D . 1984 Nature 310: 249–251
Graf T . 1992 Curr. Opin. Genet. Dev. 2: 249–255
Heckman CA, Mehew JW, Ying GG, Introna M, Golay J, Boxer LM . 2000 J. Biol. Chem. 275: 6499–6508
Hogg A, Schirm S, Nakagoshi H, Bartley P, Ishii S, Bishop JM, Gonda TJ . 1997 Oncogene 15: 2885–2898
Kirsch IR, Bertness V, Silver J, Hollis GF . 1986 J. Cell. Biochem. 32: 11–21
Lachman HM, Cheng G, Skoultchi A . 1986 Proc. Natl. Acad. Sci. USA 82: 6480–6484
Li JP, D'Andrea AD, Lodish HF, Baltimore D . 1990 Nature 343: 762–764
Lipsick JS . 1996 Oncogene 13: 223–235
Lyon JJ, Watson RJ . 1995 Differentiation 59: 171–178
Lyon JJ, Watson RJ . 1996 Gene 182: 123–128
Marks PA, Richon VM, Rifkind RA . 1996 Int. J. Hematol. 63: 1–17
Marks PA, Rifkind RA . 1978 Ann. Rev. Biochem. 47: 419–448
Matushansky I, Radparvar F, Rekhtman N, Skoultchi A . 2000 Front. Biosci. 5: D488–D492
McClinton D, Stafford J, Brents L, Bender TP, Kuehl WM . 1990 Mol. Cell. Biol. 10: 705–710
Moreau-Gachelin F, Ray D, Mattei MG, Tambourin P, Tavitian A . 1989 Oncogene 4: 1449–1456
Moreau-Gachelin F, Tavitian A, Tambourin P . 1988 Nature 331: 277–280
Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott Jr WJ, Potter SS . 1991 Cell 65: 677–689
Nakagoshi H, Kanei-Ishii C, Sawazaki T, Mizuguchi G, Ishii C . 1992 Oncogene 7: 1233–1240
Nomura N, Takahashi M, Matsui M, Ishii S, Date T, Sasamoto S, Ishizaki R . 1988 Nucleic Acids Research 16: 11075–11089
Oh IH, Reddy EP . 1999 Oncogene 18: 3017–3033
Ramsay RG, Ikeda K, Rifkind RA, Marks PA . 1986 Proc. Natl. Acad. Sci. USA 83: 6849–6853
Rao G, Rekhtman N, Cheng G, Krasikov T, Skoultchi AI . 1997 Oncogene 14: 123–131
Reiss K, Travali S, Calabretta B, Baserga R . 1991 J. Cell. Physiol. 148: 338–343
Richon VM, Ramsay RG, Rifkind RA, Marks PA . 1989 Oncogene 4: 165–173
Saville MK, Watson RJ . 1998 Adv. Cancer Res. 72: 109–140
Schmidt M, Nazarov V, Stevens L, Watson R, Wolff L . 2000 Mol. Cell. Biol. 20: 1970–1981
Spadaccini A, Tilbrook PA, Sarna MK, Crossley M, Bieker JJ, Klinken SP . 1998 J. Biol. Chem. 273: 23793–23798
Stanton LW, Watt R, Marcu KB . 1983 Nature 303: 401–406
Taylor D, Badiani P, Weston K . 1996 Genes Dev. 10: 2732–2744
Todokoro K, Watson RJ, Higo H, Amanuma H, Kuramochi S, Yanagisawa H, Ikawa Y . 1988 Proc. Natl. Acad. Sci. USA 85: 8900–8904
Trauth K, Mutschler B, Jenkins NA, Gilbert DJ, Copeland NG, Klempnauer KH . 1994 EMBO J. 13: 5994–6005
Weber BL, Westin EH, Clarke MF . 1990 Science 249: 1291–1293
Westin EH, Gallo RC, Arya SK, Eva A, Souza LM, Baluda MA, Aaronson SA, Wong-Staal F . 1982 Proc. Natl. Acad. Sci. USA 79: 2194–2198
Yen A, Samuel V, Forbes M . 1992 J. Cell. Physiol. 153: 147–156
Zhuo S, Fan S, Huang S, Kaufman S . 1995 Proc. Natl. Acad. Sci. USA 92: 4234–4238
Zobel A, Kalkbrenner F, Vorbrueggen G, Moelling K . 1992 Biochem. Biophys. Res. Comm. 186: 715–722
Acknowledgements
The authors thank Dr Shoshanna Segal and Constance Cultraro for help and advice with detection of MAD-1 protein, Dr Kathleen Weston for providing plasmids and Drs Amy Bouton and Adam Goldfarb for critical reading of the manuscript. This work was supported in part by grant support (GM55985) to TP Bender from the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, J., Kremer, C. & Bender, T. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state. Oncogene 21, 1859–1869 (2002). https://doi.org/10.1038/sj.onc.1205003
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205003
- Springer Nature Limited
Keywords
This article is cited by
-
v-Myb represses the transcription of Ets-2
Oncogene (2007)
-
Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8
Nature Methods (2006)
-
The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells
Oncogene (2006)